Feedback / Questions
arsenic trioxide oral (QTX-2101) - Quetzal Therapeutics
https://www.globenewswire.com/news-release/2026/01/29/3228847/0/en/QTX-2101-Awarded-FDA-Fast-Track-Designation-for-the-Treatment-of-Acute-Promyelocytic-Leukemia.html
Jan 29, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next